Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 25;13:978865. doi: 10.3389/fimmu.2022.978865

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Huang, Zhou, Tóth and Hajdu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

In-vitro validation of essential genes (i.e., DLAT, LIPT1, and LIAS) as potential diagnostic biomarkers in PAAD. (A) Results of RT-qPCR of DLAT, LIPT1, and LIAS in HPDE6-C7, CFPAC-1, PANC-1, SW1990, and AsPC-1 cell lines, respectively. (B) Results of western-blot in triple repletion utilizing the aforementioned cell lines. (C) IFS slides in 100X and 400X magnification demonstrated the expressional abundance of these proteins of interest in HPDE6-C7 and AsPC-1 cell lines. (D) Evaluation of the eligibilities of DLAT, LIPT1, and LIAS serving as diagnostic biomarkers in PAAD.